Testing treatments for recent dry or productive cough
Part of Lungs & breathing clinical trials.
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a new cough (dry or productive) that started within the last 3 weeks, along with a cold, sore throat, or viral infection.
- If you have a sore throat, it must not be bacterial (tested negative or low risk).
- You are not taking other cough medicines, inhalers, heart medications that cause cough, or antibiotics.
- You do not have chronic lung disease (like asthma or COPD), chronic sinus infections, a weakened immune system, or any other serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
This study is creating a new questionnaire to measure how well people can control their cough. It includes people with different types of cough and a small number of healthy volunteers.
This study tests treatments for the common cold, sinus pain, or sore throat caused by a virus. It compares different options to see which works best for reducing symptoms like runny nose, congestion, and cough.
This study tests different treatments to help ease sore throat pain and symptoms caused by viral throat infections. It aims to find the best way to relieve discomfort when you have pharyngitis, tonsillitis, or a viral sore throat that started recently.
This study tests an investigational drug called HW091077 for people with chronic cough that doesn't improve with usual treatments or has no clear cause. The drug targets a protein involved in the cough reflex and may help reduce coughing.
This trial tests whether an extended-release medication called nalbuphine can reduce coughing in people with chronic cough that hasn't improved with other treatments. You may be eligible if you've had a persistent cough for at least a year and have already tried treatments for conditions that could cause it.
Hear when a new Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.